Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Annelise Capossela/Axios

A bipartisan commission is recommending an "Apollo Program" to enhance U.S. biodefense — including against engineered viruses.

Why it matters: COVID-19, which will cost millions of lives and trillions of dollars, shuts the door on any argument that new diseases aren't a major global threat. But as biotechnology improves, we especially need ways to detect and deter pathogens designed by human beings, not just by nature.

Driving the news: On Tuesday, the Bipartisan Commission on Biodefense released a set of recommendations outlining how the U.S. could end pandemic threats — both natural and man-made — by 2030.

  • The commission — which is co-chaired by former Sen. Joe Lieberman and former Homeland Security Secretary Tom Ridge — argues for spending up to $10 billion a year to speed up vaccine prototypes, enhance genomic sequencing capabilities, and create a national public health data system, among other recommendations.

Details: The report's conclusions are solid, and they're bolstered by the fact that the commission made much the same argument in 2015, years before COVID-19. But I was particularly interested to see the attention paid to the threat of man-made pathogens.

  • The report noted that "advances in biotechnology have also made it easier to obtain or modify these pathogens, creating the possibility of pandemics emerging from deliberate attacks or laboratory accidents."
  • The commission focused on the need to develop techniques to "distinguish natural and engineered DNA and to inform attribution" of any new pathogens.

What's next: In a recent competition, hundreds of teams around the world developed algorithms designed to predict the origin of genetically engineered DNA sequences.

  • The best teams were able to predict the source lab of an unfamiliar engineered DNA sequence over 95% of the time, an improvement over the top previous results.
  • Such algorithms can be useful for regulating genetic engineering by ensuring that any edited sequences can be tied back to their point of origin.
  • But none of the algorithms would be able to determine for sure whether an unknown DNA sequence was natural or engineered, notes Lane Warmbrod, a senior analyst at the Johns Hopkins Center for Health Security.

The bottom line: We can't stumble blindly into a world where DNA can be engineered like computer code.

Go deeper

Updated 2 hours ago - Politics & Policy

Top Pentagon officials contradict Biden on Afghanistan advice

Photo: Carolone Brehman/Pool/AFP via Getty Images

Top military leaders confirmed in a Senate hearing Tuesday they recommended earlier this year that the U.S. keep 2,500 troops in Afghanistan, and that they believed withdrawing those forces would lead to the collapse of the Afghan military.

Why it matters: Biden denied last month that his top military advisers wanted troops to remain in Afghanistan, telling ABC's George Stephanopoulos: "No one said that to me that I can recall."

Poll: Latinas more likely to open their own businesses, despite pandemic setbacks

Janie Isidoro, owner of My Corazon, a Chicano business in downtown Hanford, Calif. Photo: Al Seib/Los Angeles Times via Getty Images

Latinas in the U.S. are more likely to own, or plan to open, their own businesses than non-Hispanic women, despite the pandemic’s disproportionate burden, a recent poll found.

Why it matters: The survey, conducted by Telemundo, the Latino Victory Foundation and Hispanics Organized for Political Equality, suggests Latinas can be a driver of growth for the U.S. even though they have faced greater COVID-19-related setbacks.

Warren opposes Fed chair Powell's renomination, calls him a "dangerous man"

Sen. Elizabeth Warren speaks during a hearing before Senate Armed Services Committee on Sept. 28. Photo: Alex Wong/Getty Images

Sen. Elizabeth Warren (D-Mass.) questioned Federal Reserve chair Jerome Powell's record on financial regulation during a hearing Tuesday, calling him a "dangerous man" and saying that she would not support his renomination for a second term.

Driving the news: While the Fed chair’s term expires in early 2022, President Biden is expected to make a decision this fall on whether to reappoint Powell or nominate another candidate.